Interim report
Page 1
123 Income Revenue from operations 2 Other income ( Refer Note 3 ) . Total Income ( 1 + 2 ) Expenses gsk GlaxoSmithKline Pharmaceuticals Limited Registered Office : Dr. Annie Besant Road , Mumbai - 400 030 CIN : L24239MH1924PLC001151 Tel No : +91 22 2495 9595 Fax No : +91 22 24959494 STATEMENT OF STANDALONE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND SIX MONTHS ENDED 30th SEPTEMBER , 2021 ( Rs . in Lakhs ) Particulars 3 months ended 30.09.2021 Preceding 3 months ended 30.06.2021 Corresponding 3 months ended 30.09.2020 6 months ended 30.09.2021 ( Unaudited ) ( Unaudited ) ( Unaudited ) ( Unaudited ) 6 months ended 30.09.2020 ( Unaudited ) Year ended 31.03.2021 ( Audited ) 99153 77346 87939 1505 3173 892 176499 4678 152804 6671 100658 80519 88831 181177 159475 319373 11019 330392 ( a ) Cost of materials consumed 14511 16714 14561 31225 25233 45264 ( b ) Purchases of stock - in - trade 22062 14129 24687 36191 39529 88011 ( c ) Changes in inventories of finished goods , stock - in- trade and work - in - progress 1784 ( 1359 ) ( 2501 ) 425 ( 2282 ) ( 2753 ) ( d ) Employee benefits expense 16001 16779 15401 32780 30593 61469 ( e ) Finance costs 35 79 88 114 196 353 ( f ) Depreciation and amortisation expense 1760 1771 ( g ) Other expenses 17356 16014 2196 15289 3531 33370 4373 7928 27794 57887 4 Total expenses 73509 64127 69721 5 Profit before exceptional items and tax ( 3-4 ) 27149 16392 19110 137636 43541 125436 258159 34039 72233 6 Exceptional items [ ( charge ) ] ( Refer Note 4 ) ( 6413 ) ( 6413 ) ( 17260 ) 7 Profit before tax ( 5 + 6 ) 27149 16392 12697 43541 27626 54973 8 Tax expense Deferred tax ( a ) Current tax ( b ) 9 Profit for the period / year ( 7-8 ) 7262 4700 4761 11962 8572 18430 ( 378 ) ( 348 ) 286 20265 12040 7650 ( 726 ) 32305 308 787 18746 35756 10 Other comprehensive income ( i ) Items that will not be reclassified to profit or loss ( ii ) Income tax relating to items that will not be reclassified to profit or loss ( 405 ) ( 274 ) 11 Total comprehensive income for the period ( 9 + 10 ) 20265 12040 7650 Paid - up equity share capital ( face value per share Rs . 10 ) Other equity ( Refer Note 6 ) 16941 16941 16941 32305 16941 102 18443 69 35551 16941 16941 132771 Earnings per share ( EPS ) ( of Rs . 10 each ) Basic and diluted EPS after Exceptional items ( Rs . ) 11.96 7.11 4.52 19.07 11.07 21.11 Basic and diluted EPS before Exceptional items ( Rs . ) 11.96 7.11 8.30 19.07 14.85 31.32 Not Annualised